JUMP REPORT
| Avg Daily Volume: 8,794,463 Market Cap: 417.32M Sector: Services Short Interest: 20.81 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: -.07/share REV: 5,380/M
___________________________________________________________
LAST QTR: EPS: -.35/share ACTUAL: -.20/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: ..01/share REV: 5,390/M
______________________________________________________
FULL YR: EPS: -.02/share REV: 21,590/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS HISTORY: 35% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -14.03, 13.58, 3.90
POTENTIAL JUMP MOVE: 12-15%
Links To Latest News and Headlines
Rite Aid shares moved sharply lower in after-hours trading only to open higher on Thursday following mixed first quarter results.
PHILADELPHIA, October 30, 2023–With fall routines and busy schedules in full swing, it can be tough to focus on your health. Rite Aid (OTC: RADCQ) makes it easy to keep your health a priority by offering an After Work Wednesday clinic at select stores, providing families a convenient opportunity to walk in and get the immunizations they need to protect themselves against the flu, COVID-19, RSV, and other viruses.
Rite Aid filed for bankruptcy following years of losses, failed mergers and opioid litigation. Filing for bankruptcy puts all pending litigation against the company on hold. Rite Aid will close more of its 2,100 stores and name a new chief executive as part of the restructuring.
Pharmacy chain Rite Aid has settled a critical dispute with drug supplier McKesson Corp to ensure that customers’ prescriptions will continue to be filled during Rite Aid’s bankruptcy, attorneys said on Tuesday. Rite Aid, which filed for Chapter 11 bankruptcy on Sunday night in New Jersey, sued McKesson the following morning, seeking to stop it from terminating a drug supply agreement that accounts for 98% of the pharmacy chain’s prescription drug sales. Joshua Sussberg, an attorney for Rite Aid, announced the settlement at a Tuesday court hearing in Trenton, saying that McKesson would continue supplying drugs at least through the end of Rite Aid’s bankruptcy case.
Rite Aid plans to close or sell more than 250 stores so far under a court-supervised restructuring process.
Analysis and trade direction are uploaded generally between noon and 1pm EST for most events. ALWAYS check back near market close for updates as the analysis can change by end of session.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
This area reserved for subscribers to the Options Intelligence Strategy. If this is something you wish to participate in, just let us know below.
NOTE: There is a significant amount of data behind the scenes in getting to the analysis in the tab above. Too much information for traders only confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.